{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:59:28Z","timestamp":1791223168556,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.molmed.2009.10.001","type":"journal-article","created":{"date-parts":[[2009,11,7]],"date-time":"2009-11-07T11:41:35Z","timestamp":1257594095000},"page":"562-570","source":"Crossref","is-referenced-by-count":79,"title":["One-carbon metabolism and schizophrenia: current challenges and future directions"],"prefix":"10.1016","volume":"15","author":[{"given":"M.O.","family":"Krebs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Bellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaell","family":"Mainguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.M.","family":"Jay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Frieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2009.10.001_bib1","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","article-title":"Schizophrenia","volume":"363","author":"Mueser","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2009.10.001_bib2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/sj.mp.4002062","article-title":"The pipeline and future of drug development in schizophrenia","volume":"12","author":"Gray","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10571-006-9062-8","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2009.10.001_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archgenpsychiatry.2007.9","article-title":"Back to the future: predicting and reshaping the course of psychotic disorder","volume":"65","author":"McGorry","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nbd.2008.11.018","article-title":"Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation","volume":"33","author":"Wood","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molmed.2009.10.001_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/schbul\/sbp017","article-title":"What we know: findings that every theory of schizophrenia should explain","volume":"35","author":"MacDonald","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.molmed.2009.10.001_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.04.011","article-title":"Schizophrenia, \u201cjust the facts\u201d: what we know in 2008. 2. Epidemiology and etiology","volume":"102","author":"Tandon","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.molmed.2009.10.001_bib8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.mp.4001642","article-title":"The neurodevelopmental model of schizophrenia: update 2005","volume":"10","author":"Rapoport","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/schbul\/sbn080","article-title":"Gene\u2013environment interaction and covariation in schizophrenia: the role of obstetric complications","volume":"34","author":"Mittal","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.molmed.2009.10.001_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/10673220500243372","article-title":"Do maternal folate and homocysteine levels play a role in neurodevelopmental processes that increase risk for schizophrenia?","volume":"13","author":"Picker","year":"2005","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajmg.b.20142","article-title":"Methylomics in psychiatry: modulation of gene\u2013environment interactions might be through DNA methylation","volume":"127","author":"Abdolmaleky","year":"2004","journal-title":"Am. J. Med. Gen. Part B: Neuropsychiatric Genet."},{"key":"10.1016\/j.molmed.2009.10.001_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","article-title":"Epigenetic regulation in psychiatric disorders","volume":"8","author":"Tsankova","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.molmed.2009.10.001_bib13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajhg.2008.01.008","article-title":"Epigenomic profiling reveals DNA methylation changes associated with major psychosis","volume":"82","author":"Mill","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2009.10.001_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","article-title":"Schizophrenia genes, gene expression and neuropathology: on the matter of their convergence","volume":"10","author":"Harrison","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","article-title":"Glutamate and schizophrenia: phencyclidine, N-methyl-d-Aspartate receptors and dopamine\u2013glutamate interactions","volume":"78","author":"Javitt","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.molmed.2009.10.001_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0074-7742(04)59011-6","article-title":"Mitochondria, synaptic plasticity and schizophrenia","volume":"59","author":"Ben-Shachar","year":"2004","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.molmed.2009.10.001_bib17","doi-asserted-by":"crossref","first-page":"e3676","DOI":"10.1371\/journal.pone.0003676","article-title":"Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression","volume":"3","author":"Ben-Shachar","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2009.10.001_bib18","doi-asserted-by":"crossref","first-page":"e4913","DOI":"10.1371\/journal.pone.0004913","article-title":"Mitochondrial variants in schizophrenia, bipolar disorder and major depressive disorder","volume":"4","author":"Rollins","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2009.10.001_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0006-3223(96)00068-6","article-title":"Disturbances of one-carbon metabolism in neuropsychiatric disorders: a review","volume":"41","author":"Smythies","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1042\/BST20060330","article-title":"S-adenosylmethionine: jack of all trades and master of everything?","volume":"34","author":"Loenen","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.molmed.2009.10.001_bib21","first-page":"209","article-title":"The administration of methionine to chronic schizophrenic patients: a review of 10 studies","volume":"8","author":"Cohen","year":"1974","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib22","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1073\/pnas.262658999","article-title":"An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability","volume":"99","author":"Tremolizzo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2009.10.001_bib23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.molmed.2009.10.001_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.mp.4001954","article-title":"Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection","volume":"12","author":"Ruzicka","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopsych.2007.07.003","article-title":"Methylation status of the reelin promoter region in the brain of schizophrenic patients","volume":"63","author":"Tochigi","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib27","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1371\/journal.pone.0000809","article-title":"GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia","volume":"2","author":"Huang","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2009.10.001_bib28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jpsychires.2006.08.006","article-title":"Global hypomethylation of peripheral leukocyte DNA in male patients with schizophrenia: a potential link between epigenetics and schizophrenia","volume":"41","author":"Shimabukuro","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.molmed.2009.10.001_bib29","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/hmg\/ddl253","article-title":"Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder","volume":"15","author":"Abdolmaleky","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2009.10.001_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bbabio.2006.01.009","article-title":"Mitochondrial oxidative stress, aging and caloric restriction: the protein and methionine connection","volume":"1757","author":"Pamplona","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2009.10.001_bib31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.ejcn.1601217","article-title":"Assessment of nutritional folate status and selected vitamin status of women of childbearing age","volume":"55","author":"Wartanowicz","year":"2001","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.molmed.2009.10.001_bib32","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0278-5846(89)90037-7","article-title":"Folic acid and psychopathology","volume":"13","author":"Young","year":"1989","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib33","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.pnpbp.2007.05.011","article-title":"Plasma homocysteine, folate and B12 in chronic schizophrenia","volume":"31","author":"Haidemenos","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib34","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.pnpbp.2008.09.009","article-title":"Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia","volume":"32","author":"Petronijevic","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(03)00200-2","article-title":"Homocysteine metabolism and B vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia","volume":"121","author":"Muntjewerff","year":"2003","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.molmed.2009.10.001_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.euroneuro.2004.12.003","article-title":"Nutritional and lifestyle determinants of plasma homocysteine in schizophrenia patients","volume":"15","author":"Stahl","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2009.10.001_bib37","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1176\/appi.ajp.162.9.1738","article-title":"Relation of plasma glycine, serine and homocysteine levels to schizophrenia symptoms and medication type","volume":"162","author":"Neeman","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.b.30179","article-title":"Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype and the risk for schizophrenia: a Dutch population based case-control study","volume":"135","author":"Muntjewerff","year":"2005","journal-title":"Am. J. Med. Gen. Part B: Neuropsychiatric Genet."},{"key":"10.1016\/j.molmed.2009.10.001_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.mp.4001746","article-title":"Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis","volume":"11","author":"Muntjewerff","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib40","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/schbul\/sbn096","article-title":"Prenatal nutritional deficiency and risk of adult schizophrenia","volume":"34","author":"Brown","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.molmed.2009.10.001_bib41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/schbul\/sbl041","article-title":"Schizophrenia and neural tube defects: comparisons from an epidemiological perspective","volume":"33","author":"Zammit","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.molmed.2009.10.001_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1017\/S0029665101000088","article-title":"Genes, folate and homocysteine in embryonic development","volume":"60","author":"Rosenquist","year":"2001","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.molmed.2009.10.001_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archpsyc.64.1.31","article-title":"Elevated prenatal homocysteine levels as a risk factor for schizophrenia","volume":"64","author":"Brown","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib44","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1095\/biolreprod.103.015800","article-title":"Homocysteine induces trophoblast cell death with apoptotic features","volume":"69","author":"Di Simone","year":"2003","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.molmed.2009.10.001_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0007114507352392","article-title":"Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations","volume":"97","author":"Burdge","year":"2007","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.molmed.2009.10.001_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/dvg.20230","article-title":"Maternal methyl supplements increase offspring DNA methylation at Axin fused","volume":"44","author":"Waterland","year":"2006","journal-title":"Genesis"},{"key":"10.1016\/j.molmed.2009.10.001_bib47","doi-asserted-by":"crossref","first-page":"14853","DOI":"10.1073\/pnas.261469998","article-title":"Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase","volume":"98","author":"Yamada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2009.10.001_bib48","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1093\/jn\/136.10.2653","article-title":"A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism","volume":"136","author":"Reed","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.molmed.2009.10.001_bib49","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.171","article-title":"Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database","volume":"40","author":"Allen","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2009.10.001_bib50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.schres.2008.06.016","article-title":"Genetic associations with schizophrenia: meta-analyses of 12 candidate genes","volume":"104","author":"Shi","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.molmed.2009.10.001_bib51","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00001756-200507130-00005","article-title":"Folate deficiency inhibits proliferation of adult hippocampal progenitors","volume":"16","author":"Kruman","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.molmed.2009.10.001_bib52","article-title":"Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study","author":"Sun","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.55782\/ane-2006-1619","article-title":"Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors","volume":"66","author":"Zieminska","year":"2006","journal-title":"Acta. Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.molmed.2009.10.001_bib54","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","article-title":"Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor","volume":"94","author":"Lipton","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2009.10.001_bib55","doi-asserted-by":"crossref","first-page":"14151","DOI":"10.1074\/jbc.M512927200","article-title":"Neuron-derived D-serine release provides a novel means to activate N-methyl-D-aspartate receptors","volume":"281","author":"Kartvelishvily","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2009.10.001_bib56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0920-9964(93)90021-A","article-title":"Abnormal serine\u2013glycine metabolism in the brains of schizophrenics","volume":"8","author":"Waziri","year":"1993","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.molmed.2009.10.001_bib57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-9964(98)00169-8","article-title":"A hyperglycinergic rat model for the pathogenesis of schizophrenia: preliminary findings","volume":"37","author":"Waziri","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.molmed.2009.10.001_bib58","first-page":"CD003730","article-title":"Glutamatergic drugs for schizophrenia","author":"Tuominen","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.molmed.2009.10.001_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrn2153","article-title":"NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders","volume":"8","author":"Lau","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.molmed.2009.10.001_bib60","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1023\/B:JOBB.0000041770.00567.4f","article-title":"Mitochondrial impairment in the developing brain after hypoxia-ischemia","volume":"36","author":"Hagberg","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.molmed.2009.10.001_bib61","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0361-9230(01)00528-7","article-title":"Electron microscopy of oligodendroglia in severe mental illness","volume":"55","author":"Uranova","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.molmed.2009.10.001_bib62","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1098-2396(199901)31:1<67::AID-SYN9>3.0.CO;2-#","article-title":"Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study","volume":"31","author":"Kung","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.molmed.2009.10.001_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15622970902806124","article-title":"Ultrastructural abnormalities of astrocytes in the hippocampus in schizophrenia and duration of illness: a postortem morphometric study","author":"Kolomeets","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib64","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001532","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib65","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.biopsych.2008.11.010","article-title":"Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis","volume":"65","author":"Regenold","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib66","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.bcp.2004.02.015","article-title":"Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders","volume":"67","author":"Ben-Shachar","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molmed.2009.10.001_bib67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0969-9961(03)00070-6","article-title":"Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine","volume":"14","author":"Ho","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molmed.2009.10.001_bib68","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1474-9728.2004.00086.x","article-title":"Folate deficiency and homocysteine induce toxicity in cultured dorsal root ganglion neurons via cytosolic calcium accumulation","volume":"3","author":"Tjiattas","year":"2004","journal-title":"Aging Cell"},{"key":"10.1016\/j.molmed.2009.10.001_bib69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1022329317218","article-title":"Homocysteine-evoked 45Ca release in the rabbit hippocampus is mediated by both NMDA and group I metabotropic glutamate receptors: in vivo microdialysis study","volume":"28","author":"Lazarewicz","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.molmed.2009.10.001_bib70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.neuint.2005.12.023","article-title":"Excitotoxic neuronal injury in acute homocysteine neurotoxicity: role of calcium and mitochondrial alterations","volume":"48","author":"Zieminska","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.molmed.2009.10.001_bib71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","article-title":"Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease","volume":"80","author":"Duan","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2009.10.001_bib72","doi-asserted-by":"crossref","first-page":"30808","DOI":"10.1074\/jbc.273.46.30808","article-title":"Homocysteine-dependent alterations in mitochondrial gene expression, function and structure","volume":"273","author":"Austin","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2009.10.001_bib73","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/sj.ejhg.5201606","article-title":"New variants in the mitochondrial genomes of schizophrenic patients","volume":"14","author":"Martorell","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2009.10.001_bib74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0920-9964(03)00011-2","article-title":"A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress","volume":"65","author":"Marchbanks","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.molmed.2009.10.001_bib75","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/jcb.20578","article-title":"Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia","volume":"96","author":"Tyagi","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molmed.2009.10.001_bib76","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/schbul\/sbm100","article-title":"Systematic association studies of mitochondrial DNA variations in schizophrenia: focus on the ND5 gene","volume":"34","author":"Bamne","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.molmed.2009.10.001_bib77","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.cdd.4401371","article-title":"Folic acid rescues nitric oxide-induced neural tube closure defects","volume":"11","author":"Weil","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2009.10.001_bib78","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2741\/2122","article-title":"Nitric oxide and mitochondria","volume":"12","author":"Brown","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.molmed.2009.10.001_bib79","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/geno.1995.1234","article-title":"Decreased cytochrome c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics","volume":"29","author":"Cavelier","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.molmed.2009.10.001_bib80","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0893-133X(99)00111-6","article-title":"Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics","volume":"22","author":"Prince","year":"2000","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2009.10.001_bib81","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archpsyc.1993.01820150007001","article-title":"Altered distribution of nicotinamide\u2013adenine dinucleotide phosphate\u2013diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development","volume":"50","author":"Akbarian","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib82","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.euroneuro.2006.12.004","article-title":"NO synthase-positive striatal interneurons are decreased in schizophrenia","volume":"17","author":"Fritzen","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2009.10.001_bib83","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0306-4522(97)00461-2","article-title":"Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics","volume":"83","author":"Bernstein","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.molmed.2009.10.001_bib84","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00001756-200403220-00020","article-title":"Expression of nNOS and soluble guanylate cyclase in schizophrenic brain","volume":"15","author":"Baba","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.molmed.2009.10.001_bib85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3940(96)12972-4","article-title":"Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma might reflect abnormalities in brain nitric oxide production","volume":"215","author":"Das","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molmed.2009.10.001_bib86","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.mp.4001116","article-title":"State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia","volume":"7","author":"Dror","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib87","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuroscience.2005.10.014","article-title":"Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia","volume":"137","author":"Steullet","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.molmed.2009.10.001_bib88","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia \u2013 a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2009.10.001_bib89","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2009.10.001_bib90","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/ars.2005.7.813","article-title":"The role of cystathionine beta-synthase in homocysteine metabolism","volume":"7","author":"Jhee","year":"2005","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.molmed.2009.10.001_bib91","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur. J.Neurosci."},{"key":"10.1016\/j.molmed.2009.10.001_bib92","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"Yao","year":"2006","journal-title":"Dis. Markers"},{"key":"10.1016\/j.molmed.2009.10.001_bib93","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1631\/jzus.2006.B0981","article-title":"Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study","volume":"7","author":"Li","year":"2006","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.molmed.2009.10.001_bib94","doi-asserted-by":"crossref","first-page":"16621","DOI":"10.1073\/pnas.0706778104","article-title":"Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence","volume":"104","author":"Gysin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2009.10.001_bib95","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00041444-200409000-00005","article-title":"Glutathione S-transferase M1 polymorphism might contribute to schizophrenia in the Korean population","volume":"14","author":"Pae","year":"2004","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.molmed.2009.10.001_bib96","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/bbrc.2001.4347","article-title":"Glutathione S-transferase M1 gene deletion might be associated with susceptibility to certain forms of schizophrenia","volume":"281","author":"Harada","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2009.10.001_bib97","doi-asserted-by":"crossref","first-page":"35785","DOI":"10.1074\/jbc.M602799200","article-title":"A functional transsulfuration pathway in the brain links to glutathione homeostasis","volume":"281","author":"Vitvitsky","year":"2006","journal-title":"J. Biol. Chem."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491409001658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491409001658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T14:19:05Z","timestamp":1710685145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491409001658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":97,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1471491409001658"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2009.10.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}